Share this post:

On September 6, Gowri Gopalakrishna will join a panel discussion at the DRIVE-AB Final Conference: Revitalizing the antibiotic pipeline, in Brussels, Belgium. The event, organized by the Drive-AB Consortium, will bring together global policy- and decision-makers, regulatory and public health experts, economists and representatives of the pharmaceutical, medical and civil society communities from across the globe to discuss the consortium’s final recommendations and their implementation.

Gowri will speak in a panel focused on the Drive A/B project’s key findings and the best strategies for moving forward. She will discuss the Methodology for the 2018 Antimicrobial Resistance Benchmark, which has been developed to evaluate how pharma companies are responding to AMR, and the synergies between the Benchmark and the DRIVE-AB results.

Related posts